Walleye Capital’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-53,498
Closed -$556K 4453
2022
Q4
$556K Hold
53,498
0.01% 1382
2022
Q3
$545K Hold
53,498
0.01% 1397
2022
Q2
$541K Sell
53,498
-200
-0.4% -$2.02K 0.01% 983
2022
Q1
$542K Hold
53,698
0.01% 964
2021
Q4
$536K Buy
+53,698
New +$536K 0.02% 946

Other funds holding OCEA

Walleye Capital's OCEA Position: Q1 2023 in Review

Walleye Capital sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q1 2023, closing a stake of 53,498 shares — an estimated $556K sold.

Walleye Capital first reported a position in OCEA in Q4 2021 and held it in 5 quarters. The position peaked at $556K in Q4 2022. 17 funds tracked by Wall St. Rank hold OCEA as of Q1 2023.

  • Walleye Capital reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Walleye Capital sold 53,498 Ocean Biomedical, Inc. Common Stock shares in Q1 2023, an estimated $556K.
  • Walleye Capital first reported a position in Ocean Biomedical, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • Walleye Capital's Ocean Biomedical, Inc. Common Stock position peaked at $556K in Q4 2022.
  • 17 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q1 2023.

Based on Walleye Capital's 13F filing for Q1 2023, filed 15 May 2023.